BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18852414)

  • 1. Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy.
    Piermarocchi S; Sartore M; Lo Giudice G; Maritan V; Midena E; Segato T
    Arch Ophthalmol; 2008 Oct; 126(10):1367-74. PubMed ID: 18852414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.
    Weigert G; Michels S; Sacu S; Varga A; Prager F; Geitzenauer W; Schmidt-Erfurth U
    Br J Ophthalmol; 2008 Mar; 92(3):356-60. PubMed ID: 18303156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.
    Iwama D; Otani A; Sasahara M; Yodoi Y; Gotoh N; Tamura H; Tsujikawa A; Yoshimura N
    Br J Ophthalmol; 2008 Oct; 92(10):1352-6. PubMed ID: 18662914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
    Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
    Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
    Chaudhary V; Mao A; Hooper PL; Sheidow TG
    Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
    Ruiz-Moreno JM; Montero JA; Barile S; Zarbin MA
    Retina; 2006; 26(6):602-12. PubMed ID: 16829800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S
    BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.
    Krebs I; Binder S; Stolba U
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):863-7. PubMed ID: 16331486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.
    Iriyama A; Obata R; Inoue Y; Takahashi H; Tamaki Y; Yanagi Y
    Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):339-44. PubMed ID: 17805556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):245-54. PubMed ID: 17674020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of vitreomacular adhesion on ranibizumab mono- and combination therapy for neovascular age-related macular degeneration.
    Waldstein SM; Ritter M; Simader C; Mayr-Sponer U; Kundi M; Schmidt-Erfurth U
    Am J Ophthalmol; 2014 Aug; 158(2):328-336.e1. PubMed ID: 24794282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
    Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
    Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].
    Gamulescu MA; Schubert K; Thormann S; Attaran M; Dueck N; Wiechens B; Spital G; Stroux A; Wachtlin J
    Klin Monbl Augenheilkd; 2009 Jan; 226(1):60-5. PubMed ID: 19173165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
    ; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ
    Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.
    Ruiz-Moreno JM; Montero JA; Zarbin MA
    Retina; 2007; 27(4):458-61. PubMed ID: 17420698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.
    Arevalo JF; Garcia RA; Mendoza AJ
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1180-5. PubMed ID: 15906068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.
    Axer-Siegel R; Ehrlich R; Avisar I; Kramer M; Rosenblatt I; Priel E; Weinberger D
    Ophthalmic Surg Lasers Imaging; 2006; 37(6):455-61. PubMed ID: 17152538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration.
    Lie S; Aue A; Sacu S; Simader C; Polak K; Schmidt-Erfurth U
    Acta Ophthalmol; 2010 Mar; 88(2):212-7. PubMed ID: 19016662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy with and without adjunctive intravitreal triamcinolone acetonide: a retrospective comparative study.
    Chan A; Blumenkranz MS; Wu KH; Wang G; Berker N; Parast LM; Sanislo SR
    Ophthalmic Surg Lasers Imaging; 2009; 40(6):561-9. PubMed ID: 19928721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.